Phathom Pharmaceuticals (PHAT) Current Assets: 2022-2025
Historic Current Assets for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $207.8 million.
- Phathom Pharmaceuticals' Current Assets fell 44.42% to $207.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.8 million, marking a year-over-year decrease of 44.42%. This contributed to the annual value of $360.1 million for FY2024, which is 9.38% down from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Current Assets is $207.8 million, which was down 5.07% from $218.9 million recorded in Q2 2025.
- Phathom Pharmaceuticals' 5-year Current Assets high stood at $397.4 million for Q4 2023, and its period low was $139.8 million during Q1 2023.
- Its 3-year average for Current Assets is $281.1 million, with a median of $264.9 million in 2025.
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 147.60% in 2023, then slumped by 44.42% in 2025.
- Phathom Pharmaceuticals' Current Assets (Quarterly) stood at $160.5 million in 2022, then skyrocketed by 147.60% to $397.4 million in 2023, then fell by 9.38% to $360.1 million in 2024, then tumbled by 44.42% to $207.8 million in 2025.
- Its Current Assets was $207.8 million in Q3 2025, compared to $218.9 million in Q2 2025 and $264.9 million in Q1 2025.